SCHEMBL984887

SCHEMBL984887

COc1ccc(OCC2CC2)c(-c2ncnc3c(C(=O)NC4CCN(C(C)=O)CC4)c[nH]c23)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 1/20 0.44
KMT2A Q03164 2/20 0.39
HTR4 Q13639 2/20 0.38
PAK1 Q13153 1/20 0.38
HSP90AA1 P07900 1/20 0.37
HSP90AB1 P08238 1/20 0.37
PDK1 Q15118 1/20 0.37
MCHR1 Q99705 3/20 0.36
TSHR P16473 1/20 0.36
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
MDM4 O15151 1/20 0.35
PRKAB2 O43741 1/20 0.35
CYP3A4 P08684 1/20 0.35
PRKAG1 P54619 1/20 0.35
PRKAA2 P54646 1/20 0.35
PRKAA1 Q13131 1/20 0.35
PRKAG3 Q9UGI9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL984587 0.94 HPGDS (0.44) HPGDSHTR4PAK1HSP90AA1HSP90AB1
SCHEMBL981830 0.93 MTNR1B (0.40) HPGDSKMT2AHTR4PAK1MCHR1
SCHEMBL981821 0.93 TBK1 (0.41) HPGDSKMT2AHTR4PAK1MCHR1
SCHEMBL984581 0.92 ALDH1A1 (0.44) KMT2ATSHRMEN1
SCHEMBL983552 0.92 BTK (0.40) HPGDSKMT2AHTR4PAK1MCHR1
SCHEMBL982592 0.91 PAK1 (0.38) HPGDSKMT2AHTR4PAK1MCHR1
SCHEMBL981807 0.91 MDM4 (0.38) HPGDSKMT2APAK1MDM4MEN1
SCHEMBL986109 0.91 HTR4 (0.40) HPGDSKMT2AHTR4PDE4APDE4B
SCHEMBL982719 0.91 HTR4 (0.40) HPGDSKMT2AHTR4PDE4APDE4B
SCHEMBL985286 0.91 KMT2A (0.37) HPGDSKMT2AHTR4PAK1MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US claimed
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES PDE5A, PDE3A, PDE2A HPGDS 651/4885KMT2A 2975/4885HTR4 1818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.